Back to Search
Start Over
The role of mucosal-associated invariant T cells in visceral leishmaniasis.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Sep 15; Vol. 13, pp. 926446. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Mucosal-associated invariant T (MAIT) cells are restricted by MR1 and are known to protect against bacterial and viral infections. Our understanding of the role of MAIT cells in parasitic infections, such as visceral leishmaniasis (VL) caused by protozoan parasites of Leishmania donovani , is limited. This study showed that in response to L. infantum , human peripheral blood MAIT cells from children with leishmaniasis produced TNF and IFN-γ in an MR1-dependent manner. The overall frequency of MAIT cells was inversely correlated with alanine aminotransferase levels, a specific marker of liver damage strongly associated with severe hepatic involvement in VL. In addition, there was a positive correlation between total protein levels and the frequency of IL-17A <superscript>+</superscript> CD8 <superscript>+</superscript> MAIT cells, whereby reduced total protein levels are a marker of liver and kidney damage. Furthermore, the frequencies of IFN-γ <superscript>+</superscript> and IL-10 <superscript>+</superscript> MAIT cells were inversely correlated with hemoglobin levels, a marker of severe anemia. In asymptomatic individuals and VL patients after treatment, MAIT cells also produced IL-17A, a cytokine signature associated with resistance to visceral leishmaniasis, suggesting that MAIT cells play important role in protecting against VL. In summary, these results broaden our understanding of MAIT-cell immunity to include protection against parasitic infections, with implications for MAIT-cell-based therapeutics and vaccines. At last, this study paves the way for the investigation of putative MAIT cell antigens that could exist in the context of Leishmania infection.<br />Competing Interests: JM, ZC, and SE are inventor of patents describing MR1 antigens and MR1 tetramers. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Moreira, Borges-Fernandes, Pascoal-Xavier, Ribeiro, Pereira, Pediongco, Araújo, Teixeira-Carvalho, de Carvalho, Mourão, Campos, Borges, Carneiro, Chen, Saunders, McConville, Tsuji, McCluskey, Martins-Filho, Eckle, Coelho-dos-Reis and Peruhype-Magalhães.)
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 36189274
- Full Text :
- https://doi.org/10.3389/fimmu.2022.926446